Bibliographic information

GuidelineLiving guidance for clinical management of COVID-19: living guidance, 23 November 2021.
Year of Publication2021
Issuing InstitutionWorld Health Organization

Recommendation

Maintained
Originally developed

In hospitalized children aged 0–18 who meet a standard case definition for multisystem inflammatory syndrome (MIS-C) and diagnostic criteria for Kawasaki disease, we suggest using corticosteroids in addition to standard of care for Kawasaki disease

Recommended in favor

Conditional

Also Featured In

This recommendation also appears in the following guidelines:

Guideline

Clinical management of COVID-19: living guideline, 23 June 2022.

Year2022
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 15 September 2022.

Year2022
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 13 January 2023.

Year2023
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 18 August 2023

Year2023
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, June 2025

Year2025
InstitutionWorld Health Organization